Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.37B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$488M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$449M |
| 4 |
Apple
AAPL
|
+$402M |
| 5 |
HES
Hess
HES
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.47B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$1.44B |
| 3 |
NVIDIA
NVDA
|
+$783M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$722M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$650M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.34% |
| 2 | Healthcare | 6.09% |
| 3 | Financials | 5% |
| 4 | Consumer Discretionary | 4.53% |
| 5 | Industrials | 4.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
iShares US Financials ETF
IYF
$4.67B
| $1.35M | ﹤0.01% |
15,835
+3,712
| +31% | +$289K |
|
3827
Theravance Biopharma
TBPH
$874M
| $1.35M | ﹤0.01% |
120,165
-107,498
| -47% | -$1.08M |
|
3828
Albany International
AIN
$2.11B
| $1.35M | ﹤0.01% |
13,723
-115,496
| -89% | -$10.1M |
|
3829
KB Financial Group
KB
$41.4B
| $1.35M | ﹤0.01% |
32,560
-8,781
| -21% | -$355K |
|
|
EXAS
3830
PUT
DELISTED
Exact Sciences
EXAS
| $1.35M | ﹤0.01% |
18,200
-106,400
| -85% | -$6.97M |
|
|
KNTE
3831
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $1.34M | ﹤0.01% |
564,932
+7,674
| +1% | +$13.6K |
|
|
DCH
3832
PUT
Dauch Corp
DCH
$1.34B
| $1.34M | ﹤0.01% |
151,600
+29,300
| +24% | +$217K |
|
|
RPTX
3833
DELISTED
Repare Therapeutics
RPTX
| $1.33M | ﹤0.01% |
182,097
+159,410
| +703% | +$892K |
|
3834
CALL
Integer Holdings
ITGR
$4.12B
| $1.33M | ﹤0.01% |
+13,400
| New | +$1.15M |
|
3835
Karyopharm Therapeutics
KPTI
$43.5M
| $1.33M | ﹤0.01% |
102,284
+27,757
| +37% | +$374K |
|
|
VGR
3836
DELISTED
Vector Group Ltd.
VGR
| $1.32M | ﹤0.01% |
117,347
-90,980
| -44% | -$987K |
|
3837
VF Corp
VFC
$5.63B
| $1.32M | ﹤0.01% |
+70,356
| New | +$1.21M |
|
|
ONC
3838
BeOne Medicines Ltd
ONC
$32.8B
| $1.32M | ﹤0.01% |
7,324
-39,783
| -84% | -$7.2M |
|
3839
Valvoline
VVV
$4.9B
| $1.32M | ﹤0.01% |
35,087
-489,471
| -93% | -$16.4M |
|
3840
Medallion Financial
MFIN
$229M
| $1.32M | ﹤0.01% |
133,503
-63,445
| -32% | -$527K |
|
3841
PUT
Coherent
COHR
$51.4B
| $1.31M | ﹤0.01% |
+30,200
| New | +$1.09M |
|
3842
CALL
StoneCo
STNE
$2.77B
| $1.31M | ﹤0.01% |
+72,900
| New | +$958K |
|
|
MURA
3843
DELISTED
Mural Oncology
MURA
| $1.31M | ﹤0.01% |
+221,441
| New | +$890K |
|
|
CLBR.U
3844
DELISTED
Colombier Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CLBR.U
| $1.31M | ﹤0.01% |
+130,000
| New | +$1.31M |
|
3845
Installed Building Products
IBP
$6.01B
| $1.31M | ﹤0.01% |
7,163
-38,338
| -84% | -$5.38M |
|
3846
PUT
Everest Group
EG
$14.5B
| $1.31M | ﹤0.01% |
3,700
| – | – |
|
3847
The Greenbrier Companies
GBX
$1.52B
| $1.31M | ﹤0.01% |
29,587
-137,006
| -82% | -$5.36M |
|
3848
Alaska Air
ALK
$5.29B
| $1.3M | ﹤0.01% |
33,400
-284,032
| -89% | -$10.1M |
|
3849
Lifeway Foods
LWAY
$455M
| $1.3M | ﹤0.01% |
97,250
+75,245
| +342% | +$950K |
|
3850
Navient
NAVI
$789M
| $1.3M | ﹤0.01% |
70,002
-298,508
| -81% | -$5.21M |
|
Similar funds
Millennium Management's Q4 2023 Portfolio in Review
As of Q4 2023, Millennium Management held 6,891 positions worth $231B, up 17% from $198B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Millennium Management deployed $7.99B of net new capital in Q4 2023, opening 816 new positions and adding to 2,304 existing holdings. Its largest new stake was Ferguson: 906,589 shares worth $175M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 9.2% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.47B trimmed.
- Millennium Management's largest Q4 2023 buy was Ferguson: 906,589 shares worth $175M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $4.37B increase.
- Millennium Management's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.47B.
- Millennium Management fully exited Activision Blizzard in Q4 2023, selling an estimated $1.44B.
- Millennium Management's ten largest holdings make up 21% of its $231B portfolio in Q4 2023.
- Millennium Management opened 816 new positions and closed 883 in Q4 2023.
- Millennium Management's portfolio value rose 17% quarter-over-quarter to $231B.
Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.